Saved in:
Bibliographic Details
Main Authors: Emma M. van Oers, Anton C. de Groot, Patrick Verolme, Norbertus A. Ipenburg, Thomas Rustemeyer
Format: Artículo Open Access
Published: Wiley 2025
Subjects:
Online Access:https://onlinelibrary.wiley.com/doi/10.1111/cod.70052
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867012883188023296
author Emma M. van Oers
Anton C. de Groot
Patrick Verolme
Norbertus A. Ipenburg
Thomas Rustemeyer
author_facet Emma M. van Oers
Anton C. de Groot
Patrick Verolme
Norbertus A. Ipenburg
Thomas Rustemeyer
Emma M. van Oers
Anton C. de Groot
Patrick Verolme
Norbertus A. Ipenburg
Thomas Rustemeyer
collection Wiley Open Access
contents Results of GC – MS Analyses of 40 Extracts of Diabetes Devices Emma M. van Oers Anton C. de Groot Patrick Verolme Norbertus A. Ipenburg Thomas Rustemeyer Contact Dermatitis ABSTRACT Background Diagnostic patch testing in patients with suspected allergic Contact Dermatitis from glucose sensors, insulin pumps, and infusion sets is seriously hampered by a lack of information on the chemical composition of these diabetes devices. Objectives To identify the chemicals present in diabetes devices. Materials and Methods Forty acetone extracts of 27 devices (10 sensors, 3 patch pumps, 12 infusion sets and 2 single adhesives) were investigated by gas chromatography—mass spectrometry. Results Two hundred eighty four individual chemicals were identified. All 40 extracts contained one or more chemicals that were previously identified as allergens in diabetes devices causing allergic Contact Dermatitis. Fourteen of 27 devices (52%) contained one or more acrylates, 8 (30%) colophonium derivatives, all 27 (100%) one or two phenolic allergens (2,4‐di‐ tert ‐butylphenol, p ‐ tert‐ butylphenol, butylated hydroxytoluene), and 9 (33%) 1‐hydroxycyclohexyl phenyl ketone. None of the other chemicals were well‐known haptens, with the exception of bisphenol A, which was present in half of the extracts, in some cases in very high concentrations. Conclusions All products investigated contained chemicals already known to be sensitizers in diabetes devices. The data can help determine the relevance of positive patch tests, facilitate targeted patch testing with potential allergens and aid in advising safer alternatives for sensitized patients. 10.1111/cod.70052 http://creativecommons.org/licenses/by-nc-nd/4.0/
doi_str_mv 10.1111/cod.70052
format Artículo Open Access
id wiley_oa_10_1111_cod_70052
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle Results of GC – MS Analyses of 40 Extracts of Diabetes Devices
Emma M. van Oers
Anton C. de Groot
Patrick Verolme
Norbertus A. Ipenburg
Thomas Rustemeyer
Contact Dermatitis
Results of GC – MS Analyses of 40 Extracts of Diabetes Devices Emma M. van Oers Anton C. de Groot Patrick Verolme Norbertus A. Ipenburg Thomas Rustemeyer Contact Dermatitis ABSTRACT Background Diagnostic patch testing in patients with suspected allergic Contact Dermatitis from glucose sensors, insulin pumps, and infusion sets is seriously hampered by a lack of information on the chemical composition of these diabetes devices. Objectives To identify the chemicals present in diabetes devices. Materials and Methods Forty acetone extracts of 27 devices (10 sensors, 3 patch pumps, 12 infusion sets and 2 single adhesives) were investigated by gas chromatography—mass spectrometry. Results Two hundred eighty four individual chemicals were identified. All 40 extracts contained one or more chemicals that were previously identified as allergens in diabetes devices causing allergic Contact Dermatitis. Fourteen of 27 devices (52%) contained one or more acrylates, 8 (30%) colophonium derivatives, all 27 (100%) one or two phenolic allergens (2,4‐di‐ tert ‐butylphenol, p ‐ tert‐ butylphenol, butylated hydroxytoluene), and 9 (33%) 1‐hydroxycyclohexyl phenyl ketone. None of the other chemicals were well‐known haptens, with the exception of bisphenol A, which was present in half of the extracts, in some cases in very high concentrations. Conclusions All products investigated contained chemicals already known to be sensitizers in diabetes devices. The data can help determine the relevance of positive patch tests, facilitate targeted patch testing with potential allergens and aid in advising safer alternatives for sensitized patients. 10.1111/cod.70052 http://creativecommons.org/licenses/by-nc-nd/4.0/
title Results of GC – MS Analyses of 40 Extracts of Diabetes Devices
topic Contact Dermatitis
url https://onlinelibrary.wiley.com/doi/10.1111/cod.70052